title: [Isolation perfusion chemotherapy using cisplatin in malignant tumors of the extremities].
abstract: Since 1960 isolation perfusion chemotherapy has been performed as a preoperative procedure combined with surgery in 226 patients with malignant tumor of the extremities in our department. In this report we presented the result of isolation perfusion chemotherapy using cisplatin (CDDP) for 27 patients since 1983. The histologic classification of the malignant tumor was osteosarcoma in 17 patients, malignant fibrous histiocytoma (MFH) of bone in 8, and other tumor in 2. The extremity was perfused with CDDP (100 micrograms/ml) for 60 minutes. Of 27 patients, 11 were treated with hyperthermic isolation perfusion. The two-year survival rate of the 15 patients with osteosarcoma was 80%, and that of the 7 patients with MFH of bone 71%. The tumor was microscopically analyzed, and the ratio of necrotic to viable tumor cells was calculated. The degree of tumor necrosis was classified as excellent (greater than or equal to 95%), good (80-94%), fair (50-79%), and poor (less than 50%). Of 16 patients, 7 were excellent, 5 good, 3 fair and 1 poor. We concluded that isolation perfusion chemotherapy using CDDP is an effective procedure combined with surgery for malignant tumor of the extremities.
authors.affiliation: Dept. of Orthopedic Surgery, Teikyo University, School of Medicine.
authors.forename: S
authors.initials: S
authors.lastname: Takeyama
authors.forename: A
authors.initials: A
authors.lastname: Tateishi
authors.forename: H
authors.initials: H
authors.lastname: Miki
authors.forename: M
authors.initials: M
authors.lastname: Yamanashi
authors.forename: I
authors.initials: I
authors.lastname: Hayashi
authors.forename: S
authors.initials: S
authors.lastname: Higaki
authors.forename: T
authors.initials: T
authors.lastname: Kozima
authors.forename: T
authors.initials: T
authors.lastname: Iizima
mesh_terms: D000293:Adolescent; D000328:Adult; D001859:Bone Neoplasms / Q000188:drug therapy / Q000601:surgery*; D010478:Chemotherapy, Cancer, Regional Perfusion; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005121:Extremities; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D012516:Osteosarcoma / Q000188:drug therapy / Q000601:surgery; D011292:Premedication
chemical_list: D002945:Cisplatin